| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Orgenesis Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 200,000 | $116,000 | $0.5800 | 04 Sep 2023 | Direct |
| ALIMERA SCIENCES INC | Chief Financial Officer | Performance-Based Restricted Stock Units | 0 | $0 | $3.83 | 16 Sep 2024 | Direct |
| ALIMERA SCIENCES INC | Chief Financial Officer | Restricted Stock Units | 0 | $0 | $3.83 | 16 Sep 2024 | Direct |
| GELESIS HOLDINGS, INC. | Chief Financial Officer | Common Stock | 431,975 | 06 May 2022 | Direct | ||
| GELESIS HOLDINGS, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 395,501 | 06 May 2022 | Direct | ||
| ALIMERA SCIENCES INC | Chief Financial Officer | Stock Option (Right to Buy) | 0 | 16 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465924101117-maltz-elliot-2024-09-16 | ALIMERA SCIENCES INC | 16 Sep 2024 | 3 | $0 | 4 | Chief Financial Officer | 18 Sep 2024, 21:54 |
| /report/000110465924034099-maltz-elliot-2024-03-11 | ALIMERA SCIENCES INC | 11 Mar 2024 | 2 | $0 | 4 | Chief Financial Officer | 13 Mar 2024, 21:19 |
| /report/000110465924001333-maltz-elliot-2024-01-02 | ALIMERA SCIENCES INC | 02 Jan 2024 | 1 | $0 | 4 | Chief Financial Officer | 04 Jan 2024, 16:02 |
| /report/000110465924001331-maltz-elliot-2024-01-02 | ALIMERA SCIENCES INC | 02 Jan 2024 | 0 | $0 | 3 | Chief Financial Officer | 04 Jan 2024, 16:02 |
| ORGS | Orgenesis Inc. | 04 Sep 2023 | 1 | +$116,000 | 4 | Chief Financial Officer | 05 Sep 2023, 17:06 |
| ORGS | Orgenesis Inc. | 01 Sep 2023 | 0 | $0 | 3 | Chief Financial Officer | 05 Sep 2023, 17:05 |
| CPSR | GELESIS HOLDINGS, INC. | 06 May 2022 | 4 | $0 | 4 | Chief Financial Officer | 09 May 2022, 16:18 |
| CPSR | GELESIS HOLDINGS, INC. | 13 Jan 2022 | 0 | $0 | 3 | CFO & Treasurer | 24 Jan 2022, 15:41 |